Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07494955

"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section"

Spinal anesthesia-induced hypotension is one of the most frequent and clinically significant complications of obstetric anesthesia, occurring in up to 50-80% of parturients undergoing elective cesarean section. Preoperative anxiety has been shown to potentiate hemodynamic instability through autonomic nervous system activation, thereby increasing susceptibility to spinal hypotension.

This prospective, randomized, controlled trial aims to evaluate the effect of a standardized 5-minute mindfulness-based breathing exercise administered immediately prior to spinal anesthesia on the hemodynamic response in pregnant women scheduled for elective cesarean section. Eligible participants will be randomized in a 1:1 ratio into two parallel groups: the Mindfulness-Based Breathing Exercise Group and the Control Group receiving standard preoperative care.

The breathing intervention consists of slow diaphragmatic breathing at a rate of approximately 6 breaths per minute (4-second inhalation through the nose, 6-second exhalation through the mouth), guided by a standardized script delivered by a trained anesthesiologist or nurse. Participants in the intervention group will be instructed to silently repeat the phrase "My body is relaxing as I exhale" with each exhalation, incorporating a mindfulness component.

The primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction. Secondary outcomes include preoperative state anxiety scores (STAI-5), early spinal hypotension incidence, heart rate changes, and vasopressor requirements.

The study will be conducted at Atatürk University Faculty of Medicine, Department of Anesthesiology and Reanimation, Erzurum, Turkey, in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Atatürk University Research Hospital

Erzurum, 25240, Turkey (Türkiye)

Location status: Recruiting

Location contact

ESRA DILARA AYBER, MD

CONTACT

[email protected]

+905077794216

aysenur dostbil, MD

PRINCIPAL_INVESTIGATOR

esra dilara ayber, MD

SUB_INVESTIGATOR

gamze nur cimilli senocak, MD

SUB_INVESTIGATOR

kamber kaseli

SUB_INVESTIGATOR

About this study

Background and Rationale Spinal anesthesia-induced hypotension is the most common hemodynamic complication in obstetric anesthesia, with reported incidence rates ranging from 50% to 80% in parturients undergoing elective cesarean section. The underlying pathophysiology involves sympathetic blockade-mediated arteriolar and venous vasodilation, resulting in decreased systemic vascular resistance and reduced venous return, further compounded by aortocaval compression exerted by the gravid uterus.

Current prophylactic strategies including left uterine displacement, fluid co-loading, and vasopressor infusion remain the standard of care. However, these pharmacological approaches may be associated with tachycardia, hypertension, and inter-individual response variability, underscoring the need for complementary non-pharmacological interventions.

Preoperative anxiety exerts measurable effects on autonomic nervous system balance, potentially amplifying sympathetic tone and increasing hemodynamic instability following neuraxial blockade. Slow, controlled breathing exercises have been shown to enhance baroreflex sensitivity and augment parasympathetic vagal activity, suggesting that a brief mindfulness-based breathing intervention may attenuate sympathetic hyperactivity through an "autonomic preconditioning" mechanism.

Randomization and Allocation Concealment Participants will be randomized in a 1:1 ratio using a computer-generated random number sequence. Allocation concealment will be ensured through sequentially numbered, opaque, sealed envelopes (SNOSE), opened only after the patient has been transferred to the operating room and immediately before spinal anesthesia induction.

Intervention Protocol Participants in the intervention arm will receive a 5-minute guided mindfulness-based breathing exercise prior to spinal anesthesia, consisting of slow diaphragmatic breathing at approximately 6 breaths per minute (4-second nasal inhalation, 6-second oral exhalation). During each exhalation, participants silently repeat: "My body is relaxing as I exhale."

Anesthesia Management All participants will receive spinal anesthesia in the sitting position with intrathecal administration of 11.2 mg hyperbaric bupivacaine + 15 mcg fentanyl + 150 mcg morphine. Hypotension will be defined as a decrease in systolic arterial pressure (SAP) exceeding 20% from baseline and treated with norepinephrine or ephedrine. Bradycardia will be defined as heart rate ≤50 bpm and treated with intravenous atropine (1 mg).

Statistical Analysis All analyses will be performed using IBM SPSS Statistics (Statistical Package for the Social Sciences) version 20. Normality will be assessed using Shapiro-Wilk and Kolmogorov-Smirnov tests. Between-group comparisons will be performed using independent samples t-test or Mann-Whitney U test as appropriate. Categorical variables will be compared using chi-square test. Statistical significance will be set at p<0.05.

Sample Size Sample size was calculated using G*Power 3.1.9.7 software. A clinically meaningful difference of 4.5 mmHg in maximum SAP decrease (effect size = 0.48) was determined to require 70 participants per group at 80% power and 95% confidence level. Accounting for potential dropout, 150 participants (75 per group) will be enrolled.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pregnant women aged 18-45 years Singleton pregnancy Gestational age 37 weeks or greater American Society of Anesthesiologists (ASA) physical status classification II Scheduled for elective cesarean section under spinal anesthesia Body mass index (BMI) 35 kg/m2 or less Ability to comprehend verbal instructions and perform the breathing exercise Provision of written informed consent

Exclusion criteria

Emergency cesarean section Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, HELLP syndrome) Placenta previa, placental abruption, or active antepartum hemorrhage Multiple pregnancy Contraindications to spinal anesthesia Failed spinal anesthesia requiring conversion to general anesthesia Chronic hypertension or chronic hypotension Known cardiac disease (arrhythmia, valvular disease, cardiomyopathy) Diabetes mellitus with autonomic neuropathy Thyroid dysfunction Chronic pulmonary disease potentially affecting respiratory pattern Body mass index greater than 35 kg/m2 Regular use of beta-blockers, calcium channel blockers, alpha-agonists, or alpha-antagonists Regular use of anxiolytics, antidepressants, sedatives, or chronic opioids Diagnosed anxiety disorder, panic disorder, major depressive disorder, or other psychiatric illness Regular use of psychiatric medications Cognitive impairment or communication difficulties Attention or compliance problems precluding adequate performance of the breathing exercise Prior regular practice of meditation, yoga, or mindfulness-based training

Treatment and study plan

Mindfulness-Based Breathing Exercise

Behavioral

"A standardized 5-minute mindfulness-based breathing exercise at approximately 6 breaths per minute (4-second nasal inhalation, 6-second oral exhalation), guided by a trained anesthesiologist or nurse using a standardized verbal script. During each exhalation, participants silently repeat: 'My body is relaxing as I exhale.'"

Other names: Slow Breathing Exercise, Controlled Deep Breathing, Mindfulness-Based Relaxation Technique

Primary outcomes

  1. Maximum Decrease in Systolic Arterial Pressure (ΔSAP_max) Following Spinal Anesthesia

    Time frame: Up to 10 minutes following spinal anesthesia induction"

    he primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction, calculated as the difference between the SAP value measured immediately prior to spinal anesthesia (T1, reference value) and the lowest SAP value recorded during the first 10 minutes post-spinal (SAP_min). Formula: ΔSAP_max = SAP_T1 - SAP_min (mmHg). SAP will be measured non-invasively at 1-minute intervals during the first 10 minutes following spinal induction.

Secondary outcomes

  1. Change in Preoperative State Anxiety Score (ΔSTAI-S5)

    Time frame: "Baseline and up to 5 minutes prior to spinal anesthesia induction"

    Change in state anxiety level assessed using the validated Turkish short form of the Spielberger State-Trait Anxiety Inventory (STAI-S5), a 5-item scale scored on a 4-point Likert scale (total score range: 5-20; higher scores indicate greater anxiety). The change score will be calculated as the difference between STAI-S5 scores measured immediately before (T0) and immediately after (T1) the 5-minute breathing exercise.

  2. Incidence of Early Spinal Hypotension

    Time frame: "Up to 10 minutes following spinal anesthesia induction"

    Proportion of participants developing hypotension, defined as a decrease in systolic arterial pressure exceeding 20% from baseline, within the first 5 minutes and within the first 10 minutes following spinal anesthesia induction. Reported as the ratio of patients experiencing hypotension to the total number of patients per group.

  3. Maximum Heart Rate Decrease (ΔHR_max) Following Spinal Anesthesia

    Time frame: "Up to 10 minutes following spinal anesthesia induction"

    : Maximum decrease in heart rate within the first 10 minutes following spinal anesthesia induction, calculated as the difference between the heart rate measured immediately prior to spinal anesthesia (T1, reference value) and the lowest heart rate recorded during the first 10 minutes post-spinal (HR_min). Formula: ΔHR_max = HR_T1 - HR_min (beats per minute).

  4. Time to First Hypotensive Episode

    Time frame: "During surgery, up to approximately 60 minutes following spinal anesthesia induction"

    Time elapsed (in minutes) from spinal anesthesia induction to the first recorded hypotensive episode, defined as a decrease in systolic arterial pressure exceeding 20% from baseline value (T1).

  5. Proportion of Participants Requiring Vasopressor Therapy

    Time frame: "Up to 10 minutes following spinal anesthesia induction"

    Proportion of participants in each group requiring administration of norepinephrine or ephedrine for the treatment of spinal anesthesia-induced hypotension within the first 10 minutes following spinal induction. Reported as percentage of patients per group.

  6. Total Vasopressor Dose Administered

    Time frame: "Up to 10 minutes following spinal anesthesia induction"

    Total cumulative dose (in micrograms for norepinephrine; in milligrams for ephedrine) of vasopressor agents administered within the first 10 minutes following spinal anesthesia induction for the treatment of hypotension.

  7. Lowest Systolic Arterial Pressure (SAP_min) Following Spinal Anesthesia

    Time frame: "Up to 10 minutes following spinal anesthesia induction"

    The lowest systolic arterial pressure value (mmHg) recorded within the first 10 minutes following spinal anesthesia induction, measured by non-invasive blood pressure monitoring at 1-minute intervals.

Study contacts

Contact information is provided by the study sponsor or research team.

aysenur dostbil, PROF. DR.

CONTACT

[email protected]

+905333676696

esra dilara ayber, MD

CONTACT

[email protected]

+905077794216

Sponsors and collaborators

Lead sponsor

Aysenur Dostbil

Other

Registry information

Official study title

"The Effect of a 5-Minute Mindfulness-Based Breathing Exercise Administered Prior to Spinal Anesthesia on Hemodynamic Response in Patients Undergoing Elective Cesarean Section: A Prospective Randomized Controlled Trial"

Acronym: BREATHE-CS

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Mar 27, 2026
Registry last updated
Apr 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.